Gain Therapeutics Inc. logo

Gain Therapeutics Inc.

GANX | NASDAQ
Chart Builder DCF Calculator
$1.95
+$0.11 (+5.98%)
At close: Sep 22, 2026, 4:00 PM ET
$1.95
$0 (0.00%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$78.48M
Enterprise Value
$65.67M
Beta
0.21
Average Volume
743.87K
Shares Outstanding (Diluted)
42.88M
Shares Change YoY
41.32%
Institutional Ownership
19.41%
Exchange
NASDAQ
ISIN
US36269B1052

Price Performance

Price Change 1M
-8.0%
Price Change 3M
4.0%
Price Change 6M
-6.1%
Price Change YTD
-42.1%
Price Change 1Y
5.8%
Price Change 3Y
-44.9%
Price Change 5Y
-75.2%
1M CAGR (ann.)
1.1%
1Y CAGR (ann.)
8.2%
5Y CAGR (ann.)
-26.3%
All-Time CAGR
-27.9%

Valuation

PE Ratio
-3.68
Forward PE
N/A
PEG Ratio
-0.13
Forward PEG
-0.12
PS Ratio
N/A
Forward PS
348.80
PB Ratio
6.95
P/FCF Ratio
-4.14
P/Adj. FCF Ratio
-3.78
P/OCF Ratio
-4.18
EV/Sales
N/A
EV/EBIT
-3.42
EV/EBITDA
-3.44
EV/FCF
-3.46
Earnings Yield
-27.2%
FCF Yield
-24.1%
Adj. FCF Yield
-26.5%

Financial Health

Net Cash
$13.08M
Total Debt
$266.19K
Cash & Short-Term Investments
$13.08M
Total Assets
$15.42M
Current Ratio
4.36
Quick Ratio
4.36
Debt / Equity Ratio
0.05
Debt / EBITDA
-0.01
Debt / FCF
-0.01
OCF / Debt
-71.20
Interest Coverage
0.00
Altman Z-Score
-1.94
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-9.7%

Returns

Return on Assets
-130.4%
Return on Equity
-161.6%
Return on Invested Capital
-157.8%
Return on Capital Employed
-160.9%
Return on Tangible Assets
-130.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
-150.0%
Revenue CAGR 5Y
-89.6%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
48.8%
EPS CAGR 5Y
26.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
0.1%
FCF CAGR 5Y
-6.9%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
8
EPS Growth Next 3Y
54.7%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.13
EPS Growth Est (next Q)
-13.3%
Revenue Est (next Q)
$33.33K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7.80
Price Target Upside
323.9%

Cash Flow

Operating Cash Flow
$-18.95M
Free Cash Flow
$-18.95M
Adj. Free Cash Flow
$-20.78M
FCF Per Share
-$0.44
OCF Per Share
-$0.44
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$0
Operating Income
$-19.29M
EBITDA
$-19.1M
Net Income
$-20.11M
EPS (Diluted)
-$0.50
Revenue / Employee
N/A
Profit / Employee
$-957.44K
Employees
21

© 2026 bestshares.com. All rights reserved.